FDA Inspection 1305610 — Immuno-Mycologics, Inc

Immuno-Mycologics, Inc — FEI 1627497

The FDA completed an inspection of Immuno-Mycologics, Inc on March 5, 2026 in Norman, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 5, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Norman, OK (United States)

Citations

IDCFRDescription
23088ISO 13485:2016 Clause 7.1Records of risk management activities in product realization not maintained
23133ISO 13485:2016 Clause 7.3.9Requirements for design and development changes not met before implementation